CD14 is involved in the modulation of immune reaction via toll-like receptors (TLR) and may influence the development of allergic diseases. The role of CD14 in vernal keratoconjunctivitis (VKC) has not yet been investigated. The aim of this study is to evaluate changes of tear soluble sCD14 and conjunctival CD14, TLR-4 and 9 expression in patients with VKC in the active and quiescent phases.
Methods:
Eighteen patients with VKC during active inflammation (group A, N = 9), in the quiescent phase (group Q, N = 5) and after recovery (group R, N = 4) and 10 healthy subjects were included. Expression of sCD14 in tears and of CD14, TLR-4, and TLR-9 by conjunctival epithelium were evaluated by Western Blot in all groups.
Results:
Expression of tear sCD14 and of conjunctival CD14, TLR-4, and TLR-9 was significantly decreased in group A when compared with healthy subjects and with VKC group Q and R. Lower expression of sCD14, CD14, TLR-4, and TLR-9 were significantly correlated with the severity of papillary reaction, while the lower sCD14 was correlated with severity of conjunctival hyperemia.
Conclusions:
Tear sCD14, and conjunctival CD14, TLR4, and TLR-9 decreased during ocular surface inflammatory reaction in patients with VKC. CD14 and TLRs ocular surface evaluation may represent biomarkers of VKC activity and novel therapeutic target.
BoniniSBoniniSLambiaseA, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology2000; 107: 1157–1163.
2.
SacchettiMAbiccaIBruscoliniA, et al. Allergic conjunctivitis: current concepts on pathogenesis and management. J Biol Regul Homeost Agents2018; 32: 49–60.
3.
SacchettiMLambiaseAMantelliF, et al. Tailored approach to the treatment of vernal keratoconjunctivitis. Ophthalmology2010; 117: 1294–1299.
4.
BoniniSSacchettiMMantelliF, et al. Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol2007; 7: 436–441.
5.
SacchettiMBaiardiniILambiaseA, et al. Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire. Am J Ophthalmol2007; 144: 557–563.
6.
BoniniSLambiaseASgrullettaR, et al. Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol2003; 3: 381–387.
7.
MaggiEBiswasPDel PreteG, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol1991; 146: 1169–1174.
8.
LambiaseAMiceraASacchettiM, et al. Toll-like receptors in ocular surface diseases: overview and new findings. Clin Sci2011; 120: 441–450.
9.
MiceraAStampachiacchiereBNormandoEM, et al. Nerve growth factor modulates toll-like receptor (TLR) 4 and 9 expression in cultured primary VKC conjunctival epithelial cells. Mol Vis2009; 15: 2037–2044.
10.
BoniniSMiceraAIovienoA, et al. Expression of toll-like receptors in healthy and allergic conjunctiva. Ophthalmology2005; 112: 1528. discussion 1548-9.
BaumannCLAspalterIMSharifO, et al. CD14 is a coreceptor of toll-like receptors 7 and 9. J Exp Med2010; 207: 2689–2701.
13.
VerhasseltVBuelensCWillemsF, et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol1997; 158: 2919–2925.
14.
SchumannRR.Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol1992; 143: 11–15.
15.
VercelliDBaldiniMSternD, et al. CD14: a bridge between innate immunity and adaptive IgE responses. J Endotoxin Res2001; 7: 45–48.
16.
BaldiniMVercelliDMartinezFD.CD14: an example of gene by environment interaction in allergic disease. Allergy2002; 57: 188–192.
17.
LeungTFTangNLWongGW, et al. CD14 and toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets Inflamm Allergy2005; 4: 169–175.
BlaisDRVascottoSGGriffithM, et al. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Investig Ophthalmol Vis Sci2005; 46: 4235–4244.
20.
ZicariAMCapataGNebbiosoM, et al. Vernal keratoconjunctivitis: an update focused on clinical grading system. Ital J Pediatr2019; 45: 64.
21.
WolffsohnJSAritaRChalmersR, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf2017; 15: 539–574.
22.
SacchettiMMiceraALambiaseA, et al. Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. Mol Vis2011; 17: 47–52.
23.
SacchettiMLambiaseACortesM, et al. Clinical and cytological findings in limbal stem cell deficiency. Graefes Arch Clin Exp Ophthalmol2005; 243: 870–876.
24.
SacchettiMSegattoMBruscoliniA, et al. Changes of NGF pathway in allergic rhinoconjunctivitis: a conjunctival allergen challenge study. Allergy2019; 74: 605–607.
25.
da RochaJTTrapaniLSegattoM, et al. Molecular effects of diphenyl diselenide on cholesterol and glucose cell metabolism. Curr Med Chem2013; 20: 4426–4434.
26.
Lødrup CarlsenKCGranumB. Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr Allergy Asthma Rep2007; 7: 436–443.
27.
MacatoniaSEHoskenNALittonM, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol1995; 154: 5071–5079.
28.
UlevitchRJTobiasPS.Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol1995; 13: 437–457.
29.
MartinezFD.CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc2007; 4: 221–225.
30.
NoresJERBensussanAVitaN, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol1999; 29: 265–276.
31.
BaldiniMLohmanICHalonenM, et al. A polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol1999; 20: 976–983.
32.
AriasMARey NoresJEVitaN, et al. Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol2000; 164: 3480–3486.
33.
MartinACLaingIAKhooSK, et al. Acute asthma in children: relationships among CD14 and CC16 genotypes, plasma levels, and severity. Am J Respir Crit Care Med2006; 173: 617–622.
34.
ZhouTHuangXMaJ, et al. Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China. Respir Res2019; 20: 19.
35.
LeonardiASatheSBortolottiM, et al. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy2009; 64: 710–717.
36.
LandmannRFisscherAEObrechtJP.Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages. J Leukoc Biol1992; 52(3): 323–330.
37.
CosentinoGSopranaEThienesCP, et al. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol1995; 155: 3145–3151.
38.
LaurielloMMiceraAMuziP, et al. TLR4 and TLR9 expression in different phenotypes of rhinitis. Int J Otolaryngol2012; 2012: 925164.
39.
BergougnanCDittleinDCHümmerE, et al. Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors. World Allergy Organ J2020; 13: 100109.
40.
VolpiCFallarinoFPallottaMT, et al. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. Nat Commun2013; 4: 1852.
41.
Rakoff-NahoumSPaglinoJEslami-VarzanehF, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell2004; 118: 229–241.
42.
RodríguezDKellerACFaquim-MauroEL, et al. Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol2003; 171: 1001–1008.
43.
DabbaghKDahlMEStepick-BiekP, et al. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J Immunol2002; 168: 4524–4530.
44.
IovienoALambiaseASacchettiM, et al. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol2008; 246: 435–441.
